Cite this: Drug-eluting Stents for Infrapopliteal Arterial Disease in the Setting of Critical Limb Ischemia - Medscape - Oct 01, 2011. Autologous vein bypass is the standard of care for ...

Expert Rev Cardiovasc Ther. 2011;9(10):1339-1346. © 2011 Expert Reviews Ltd. Cite this: Drug-eluting Stents for Infrapopliteal Arterial Disease in the Setting of ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

DEEPER OUS is a prospective, nonrandomized, multicenter, single-arm trial taking place in New Zealand, Germany, and Switzerland ...

The data thus far suggest fewer repeat interventions with the newly FDA approved resorbable device compared with PTA.

The Disrupt PAD BTK II study’s 30-day outcomes were revealed. The core lab–adjudicated, prospective, multicenter, s ...

Vascular. 2020 Mullins, CH et al “Prevalence and Outcomes of Endovascular Infrapopliteal Interventions for Intermittent Claudication” accepted for publication, Annals of Vascular Surgery 2020 Spangler ...

J Vasc Surg 2000; 32:961-8. Passman MA, Marston WA, Carlin RE, Farber MA, Burnham SJ, Archie JP, Keagy BA. Long-term results of infrapopliteal bypass using polytetrafluorethylene and Taylor vein patch ...

Bolt Medical today announced the completion and results of the RESTORE ATK and RESTORE BTK pivotal clinical trials investigating the company's Bolt IVLTM Above the Knee (ATK) and Below the Knee (BTK) ...